This bill requires health insurers in New Jersey to provide coverage for self-measured blood pressure monitoring for subscribers diagnosed with preeclampsia. The coverage includes supplying a validated home blood pressure monitor and reimbursement for healthcare provider time spent educating subscribers on its use and data interpretation. The mandate applies to various health insurance contracts, including those from hospital service corporations and health maintenance organizations. The legislation aims to improve maternal health outcomes by ensuring access to monitoring tools and education, facilitating early detection of high blood pressure, and potentially reducing risks associated with preeclampsia. Additionally, it includes provisions for Medicaid coverage for eligible individuals diagnosed with preeclampsia, pending federal approvals.

The bill also mandates that the Commissioner of Health require healthcare facilities and practitioners to provide validated home blood pressure monitors at no cost to pregnant patients diagnosed with preeclampsia or those concerned about their blood pressure. It emphasizes the distribution of educational materials about preeclampsia during the first pregnancy visit. Furthermore, the Division of Medical Assistance and Health Services will cover self-measured blood pressure monitoring under Medicaid for eligible individuals, with provisions for patient training and health outcome reporting. The bill allocates $1 million for reimbursement claims related to the monitors and training, with unspent funds carried over to the next fiscal year. The Commissioner of Health is tasked with reporting on the initiative's effectiveness to ensure accountability and track health outcomes.